aod9604 peptide before and after Breaking through weight loss plateaus with alternative peptides AOD-9604 and MOTS-C Peptides Therapy

Nobles' Weight Loss Clinic in San Antonio

in the Journal of Endocrinology and Metabolism reported AOD 9604 to be well-tolerated across tested doses, with no observed alterations in IGF-1 levels, blood glucose, or insulin sensitivity

This metabolic shift occurs due to the peptides action on the nicotinamide methylation pathway , which increases intracellular NAD+ availability, facilitating greater oxidative metabolism

By doing so, it improves metabolism and weight control

More recent peer-reviewed research has investigated AOD-9604 in chondroprotection and osteoarthritis models

Equivalent effects have not been established in people